US Patent Issued to CELLICO on Nov. 25 for "Augmented reality devices for patients with retinitis pigmentosa and macular degeneration" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,482,382, issued on Nov. 25, was assigned to CELLICO Inc. (Seongnam-si, South Korea).

"Augmented reality devices for patients with retinitis pigmentosa and macular degeneration" was invented by Ho Sung Kang (Paju-si, South Korea) and Jong Gi Hong (Incheon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides an augmented reality (AR) device for patients with retinitis pigmentosa and macular degeneration comprising a map providing unit, a region setting unit, and a region display unit, wherein the map providing unit sequentially drives a plurality of scanning points included in a display of wearable glasses to provide...